Items where authors include "Waterston, A."

Article

Dayimu, A. orcid.org/0000-0001-9998-7463, Gupta, A., Matin, R.N. et al. (25 more authors) (2024) A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM). European Journal of Cancer, 196. 113455. ISSN 0959-8049

Conference or Workshop Item

Gkountouras, G. orcid.org/0000-0003-2093-5359, Meads, D., Mujica-Mota, R. et al. (16 more authors) (2025) LBA2 The DANTE phase III trial comparing 1 year versus 2 years of anti-PD1 immunotherapy as first-line treatment for metastatic melanoma: Health economics analysis. In: ESMO Immuno-Oncology Congress 2025, 10-12 Dec 2025, London, United Kingdom.